Podcasts about colorectal

Colorectal cancer has long been thought of as a disease of older folks. But that's changing — fast. Rates in older people are actually going down, and more and more people under 50 are getting this disease. And a surprising number of them are dying from it. So what's going on here? We dig into why young people are getting hit harder. Plus, we often hear that you should watch out for changes in your poo. But what changes?? We'll find out. We talk to gastrointestinal medical oncologist Dr. Michael Foote and cancer biologist Prof. Ludmil Alexandrov. Find our transcript here: https://tinyurl.com/ScienceVsColonCancer In this episode, we cover: (00:00) Becca's story (05:52) What the rise looks like (09:06) Is there something different about this cancer? (14:13) What symptoms to look out for (17:41) Why is this happening? (21:34) The hunt for explanations This episode was produced by Michelle Dang, with help from Rose Rimler, Meryl Horn and Ekedi Fausther-Keeys. Wendy Zukerman is our executive producer. We're edited by Blythe Terrell. Fact checking by Erica Akiko-Howard. Mix and sound design by Bobby Lord and Bumi Hidaka. Music written by Bobby Lord, Bumi Hidaka, So Wylie, Emma Munger and Peter Leonard. And thank you to Prof. Caitlin Murphy. Science Vs is a Spotify Studios Original. Listen for free on Spotify or wherever you get your podcasts. Follow us and tap the bell for episode notifications. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Host Janet Michael sits down with Dr. Michael Avery, board-certified general surgeon, Colorectal surgery specialist with Valley Health Surgical Oncology at Winchester Medical Center  to discuss colorectal cancer — why awareness matters, who's at risk, how to screen, and how far treatment has come. Dr. Avery brings both personal backstory and clinical expertise to a conversation that could save your life. About Dr. Avery Originally from Charlotte, NC; discovered medicine through a hospital internship Completed undergrad at East Carolina University, medical school at Campbell University General surgery residency at Carolinas Medical Center; colorectal fellowship at UT Southwestern in Dallas Now practicing at Valley Health Surgical Oncology, Winchester Medical Center Colorectal Cancer by the Numbers 3rd most commonly diagnosed cancer in men and women 2nd leading cause of cancer death 150,000+ diagnoses in 2023; approximately 50,000 deaths Nearly half of cases are linked to modifiable risk factors Screening: What You Need to Know Screening should begin at age 45 for average-risk individuals (lowered from 50) If a first-degree relative was diagnosed, begin screening 10 years before their diagnosis age Gold standard: Colonoscopy — both diagnostic and therapeutic in one procedure Alternative options: Cologuard (DNA stool test, ~94–95% sensitivity), CT colonography A positive Cologuard result requires follow-up colonoscopy Colonoscopy prep and sedation have improved significantly — most patients feel comfortable and remember nothing Warning Signs & Symptoms Rectal bleeding (hematochezia) Abdominal pain Changes in bowel habits (constipation or diarrhea) Iron deficiency anemia Unintentional weight loss Blood mixed in stool Note: Do not dismiss these symptoms at any age — young-onset colorectal cancer is rising Risk Factors Non-modifiable: Family history, inflammatory bowel disease, genetics Modifiable: Sedentary lifestyle, obesity, diet high in processed meats/red meats/refined grains/sugar-sweetened beverages, smoking, excess alcohol Consuming 2+ sugar-sweetened beverages per day associated with nearly 2x increased risk Who's Most at Risk Men are more prone than women and have higher mortality rates African American men face a disproportionately higher risk and younger onset Young-onset colorectal cancer is increasingly left-sided and rectal, which can be more life-altering Advances in Treatment Minimally invasive surgery: hospital stays now typically 1–3 days Total neoadjuvant therapy for rectal cancer — organ preservation approach ("watch and wait") to potentially avoid surgery Targeted therapies and immunotherapies showing remarkable response rates for certain genetic profiles (e.g., work from Memorial Sloan Kettering) Early-stage colon cancer has an 85–90% five-year survival rate Key Takeaways Colorectal cancer is largely preventable and highly treatable when caught early. Get screened at 45 — or earlier if you have a family history. Don't ignore symptoms — rectal bleeding and bowel changes deserve prompt evaluation. A colonoscopy is the gold standard: one test, one time, can both find and fix the problem. Treatment today looks nothing like it did for your grandparents' generation. Resources & Next Steps Talk to your primary care physician about scheduling a colonoscopy or Cologuard test Contact Valley Health Surgical Oncology at Winchester Medical Center to learn more about colorectal cancer screening and treatment Learn more at valleyhealthlink.com

Colorectal cancer is one of the few cancers that can often be prevented through screening, yet far too many people aren’t getting screened on time. In this episode of Medically Speaking, Dr. Eve Glazier welcomes back the show’s very first guest, award-winning journalist Katie Couric, for an ongoing conversation and call to action for Colorectal Cancer Awareness Month. Joined by Fola May, MD, PhD, UCLA gastroenterologist, and researcher, they discuss what’s changed in the conversation around colorectal cancer, why screening matters more than ever, the symptoms people should never ignore, and how to choose among today’s screening options. They also explore the barriers that keep people from follow-through — and why turning awareness into action can save lives. Find Dr. Glazier online at: https://www.uclahealth.org/medicallyspeakinghttps://www.instagram.com/uclahealthmedicallyspeakinghttps://www.tiktok.com/@uclamedicallyspeaking https://www.instagram.com/dreveglazierSee omnystudio.com/listener for privacy information.

Colorectal cancer is one of the leading causes of cancer deaths in the U.S. But when it's caught early, the survival rate is around 90 percent, according to the Colorectal Cancer Alliance.MPR News host Angela Davis talks about symptoms that shouldn't be ignored, common misconceptions about family history, and what treatment looks like today.

Colorectal health is one of the most overlooked—and most quietly essential—parts of our wellbeing. From common concerns like constipation, hemorrhoids, and anal fissures to lifesaving screenings like colonoscopies, the colon tells an important story about our overall health. Yet embarrassment and stigma often keep people from talking openly about symptoms that are incredibly common and treatable. Why do so many of us feel shame around a system that everybody relies on? When should we stop ignoring discomfort and start paying closer attention to what our gut may be trying to tell us? Do at-home remedies, like daily fiber supplements, Sitz baths, and hemorrhoidal creams, actually work?In this episode, we are joined by Dr. Albert Chung, MD, FACS, MBA, FASCRS (known online as Your Friendly Proctologist with over 200,000 subscribers on YouTube), a double board-certified general and colorectal surgeon based in Rancho Santa Margarita, California. Dr. Chung received his MD from the University of Illinois at Chicago, where he also completed his 5-year General Surgery residency. He then completed his Colon and Rectal Surgery fellowship at Henry Ford Health System in Detroit, Michigan. Dr. Chung has been featured in TIME Magazine.Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

Colorectal cancer is rising in younger adults and is now the leading cause of cancer-related death for Americans under 50. Dr. Ross Meidinger, from Dakota Gastroenterology, joins Amy and JJ to discuss. Visit them at: dakotagi.com or call 701-356-1001See omnystudio.com/listener for privacy information.

Does bacon cause cancer? The evidence is overwhelming. A new national survey conducted for the Physicians Committee reveals that nearly half of Americans are unaware that processed meat increases colorectal cancer risk. But the real story isn't just awareness — it's prevention. In this episode of The Exam Room Podcast Chuck Carroll is joined by registered dietitian Anna Herby to explain: ✅ How eliminating processed meat can lower colorectal cancer risk ✅ Why fiber is one of the most powerful cancer-fighting nutrients ✅ The safest and healthiest alternatives to bacon, sausage, burgers, and deli meat ✅ What a "colon-protective plate" looks like ✅ How plant-based proteins support gut microbiome health ✅ Practical grocery store swaps you can make immediately Processed meats like bacon, hot dogs, and sausage are classified as Group 1 carcinogens. But replacing them with beans, lentils, tofu, tempeh, whole grains, and vegetables can significantly improve colon health and reduce inflammation. Colorectal cancer is rising in younger adults — but it's also one of the most preventable cancers. Watch now to learn how small can make a big difference.

durée : 00:03:00 - Mars bleu : Le mois du dépistage du cancer colorectal en Mayenne - Le cancer colorectal est responsable de 17 000 morts chaque année en France. En Mayenne, de nombreuses actions sont prévues pour Mars bleu, le mois dédié à la prévention et au dépistage de cette maladie qui peut être soigné très facilement s'il est pris en charge tôt. Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

Hello, and welcome to the March 2026 Interoffice Memo!  These 'top of the month' episodes are meant to serve as reminders for important milestones throughout the year so I'm not posting standalone episodes about DST, taxes, or holiday party planning.  There may even be a dash of current events sprinkled in from time to time, so buckle up, tune in, and take notes.  xo Jess 5Calls.org is your friend here in the US.  They'll help you contact the right people for your city/state/district/county, and give you ideas for what you might say.  You can call 24/7!  No need to wait for business hours, and some folks find it easier to leave a voicemail, although I can personally attest that staffers at elected official offices are kind, diligent, and make it easy to voice your opinions. British Colombia is adopting year-round DST!  I'm so happy for (and jealous of) them.  :) Last week, I had my first colonoscopy.  Colorectal cancer is the second leading cancer here in the US.  Eat your fiber, drink your water, move your body, and get your preventative screenings. ----- I, Jess Lindgren, host of this podcast, believe that empathy is not a weakness; it is a strength, and, like so many things in this life, a practice.  It is not a radical position to say 'stop killing children and other grownups, please and thank you.'  The value and worth of every human being on this earth is not up for debate.  I'll leave you with this quote, which is both timely and evergreen:   To all the people still saying they're "not political" right now: that choice is political. Choosing normalcy while your neighbors are being targeted, detained, and stripped of their rights is a position, whether you admit it or not. Comfort is a privilege. Silence is participation. History doesn't remember neutrality kindly. If you can afford not to care, it's because someone else is paying the price.

durée : 00:21:56 - Le dépistage du cancer colorectal avec la CPAM de Pau Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

AI and the future of journalism In February, "Ideastream Explores: Artificial Intelligence" covered the myriad ways AI is rapidly evolving and changing our lives. It's impacting how students learn, reshaping the workforce, and we're learning more and more about the environmental costs of data centers and the massive processing power needed for generative AI programs. Ideastream hosted a "Sound of Ideas Community Tour" at the Idea Center and took part in another live event as well, about the intersection of journalism and artificial intelligence and concerns the public has about how we might be using it and what guardrails we're setting in place. The Akron Press Club has pulled together a panel today to talk about the choices newsroom are making and what the next generation of journalists are being taught about AI. Guests: - Andrew Meyer, Deputy Editor, Ideastream Public Media - Phil Trexler, Editor-in-Chief, The Marshall Project - Cleveland - Mizell Stewart, Professor-in-Residence, Kent State University Colorectal Cancer Rates Colorectal cancer is now the leading cause of cancer deaths among people younger than 50 in the United States, according to the Journal of the American Medical Association. The recent deaths of actors James Van Der Beek and Catherine O'Hara have brought renewed attention to the disease. While most cases still occur in people over 50, rates among younger adults are rising. Screening guidelines from the American Cancer Society adopted in 2018 now recommend that average-risk adults begin screening at 45 instead of 50. Colorectal cancer is highly treatable when detected early, and experts say screening options, including colonoscopies and at-home stool tests, are saving lives. Guests: - Joshua Sommovilla, M.D., Colon and Rectal Surgical Oncologist, Cleveland Clinic - Mengdan Xie, M.D., Gastroenterology, MetroHealth - Amy Fogerty, Teacher, Shaker Heights High School

Ecoutez Ça va beaucoup mieux avec Jimmy Mohamed avec Agathe Landais du 02 mars 2026.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

On this Make A Difference Minute, Dr. James T. McCormick of the American College of Surgeons explains why early detection is one of the most powerful tools we have against colorectal cancer. Colorectal cancer is being diagnosed more often in adults under 50, and symptoms are frequently overlooked. Dr. McCormick shares why warning signs like rectal bleeding or ongoing changes in bowel habits should never be ignored, regardless of age. When caught early, colorectal cancer is often highly treatable, and in some cases, screening can even prevent cancer before it starts. Early action saves lives. Awareness changes outcomes. Sponsor: Singing River Dentistry SingingRiverDentistry.com

durée : 00:05:55 - Bienvenue chez vous, l'invité - À l'occasion de Mars Bleu, le mois de sensibilisation au dépistage du cancer colorectal, le docteur Jacques Duclieu, gastro-entérologue, diplômé de cancérologue digestive et vice président du comité de l'Ardèche tire la sonnette d'alarme sur ici Drôme Ardèche. Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

In this new episode of Speaking of Surgonc, Dr. Rick Greene & Dr. Elena Panetti discuss the article: Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases, from the January 2026 issue of the Annals of Surgical Oncology.

Interview with Joseph Valentino, MD

Colorectal cancer (cancer of the colon and rectum) is now the leading cause of cancer deaths in adults younger than 50. Rates have increased steadily over the past three decades, with the most dramatic rise seen in people in their 20s and 30s. In this episode we break down what that means for you and the people you love.  https://bit.ly/3OpPlk8Early colorectal cancer often has no symptoms at all, which is why screening guidelines were recently lowered to begin at age 45. When caught early, the five-year survival rate is 91%. When detected after it has spread, survival drops dramatically.We discuss:Why colorectal cancer is increasing in younger adultsThe subtle symptoms many people ignoreHow blood clots can complicate cancerLifestyle factors linked to riskWhy early-onset colorectal cancer tends to be more aggressiveHow to advocate for yourself if something feels “off”If you notice blood in your stool, persistent abdominal pain, changes in bowel habits, unexplained weight loss, or fatigue from anemia — do not dismiss it. Speak up. Get evaluated. Early detection can save your life.In this Episode:0:00 – Intro: Colorectal Cancer Cancer in Young Adults02:35 – Recipe: Yummy Ham & Pickle Rollups02:50 – “André Is An Idiot”: André Ricciardi's Terminal Creative Legacy 05:38 – Celebrity Case Studies: James Van Der Beek & Catherine O'Hara14:32 – Super Bowl Ad Alert: Multi-Cancer Tests & False Negatives16:54 – The Reality Check: Lifestyle Risks & Charlie's Personal Disclosure30:44 – Tracey Emin: Reclaiming Life After Radical Pelvic Surgery34:00 – Outro#ColorectalCancer #AndréRicciardi #TraceyEmin #JamesVanDerBeek #CatherineOHara #ColonCancer #CancerScreening #EarlyDetection #YoungAdultsHealth #CancerAwareness #PreventCancer #EveryoneDiesPodcast #KnowTheSigns #AdvocateForYourHealth Support the showGet show notes, images and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

Colorectal cancer is now the leading cause of cancer deaths for Americans under the age of 50, according to a paper published last month in JAMA. This research backs up a trend that doctors have been seeing for a while now: Colon cancer isn’t just a disease that affects older people. Just last week, James Van Der Beek, who played Dawson on “Dawson’s Creek” died of colorectal cancer. He was 48 years old. In the past few years, more health organizations have followed the American Cancer Society in lowering the recommended age for colon cancer screenings from 50 to 45 years old. And more recently, there’s been a trend online that encourages people to start “fibermaxxing”... which is just a fancy way of telling them to eat more fiber. We talk to a doctor about this trend and the symptoms to look out for when it comes to colon cancer. Guests: Dr. Rachel Issaka, director of the colorectal cancer screening program for the Fred Hutchinson Cancer Center and UW Medicine Related links: Leading Cancer Deaths in People Younger Than 50 Years | Breast Cancer | JAMA | JAMA Network Colorectal Cancer Is Now the Top Cause of Cancer Death in Younger People - WSJ Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

The nation is still recovering after the devastating death of Dawson's Creek star, James Van der Beek. Colorectal cancer has been on the rise in young adults for years and is now the leading cause of cancer deaths overall in this age group. We spoke with wellness coach, Amy Llinas, about ways to lower the risk of getting this cancer.

Colorectal cancer is rising quickly among young adults – in fact, it's the leading cause of cancer deaths for adults under 50 in the United States. And after actor James Van Der Beek's diagnosis and death at 48, many are wondering how to tell when everyday symptoms might actually be something more serious. On this week's Paging Dr. Gupta, we break down the red flags and tell you what to know about screening. Plus, vibration plates are popping up in gyms and living rooms — but do they actually deliver the benefits they promise?  More on what's behind the rise of colon cancer in young people with Dr. Kimmie Ng. This episode was produced by Andrea Kane, Jennifer Lai and Kyra Dahring.  Showrunner: Amanda Sealy  Senior Producer: Dan Bloom Technical Director: Dan Dzula Learn more about your ad choices. Visit podcastchoices.com/adchoices

February 16, 2026 ~ Marco Rubio lays out Trump administration's foreign policy agenda. Aric Nesbitt weighs in on Whitmer's latest budget and calls for federal investigation of state run non profits. Colorectal cancer has become the number one killer of people under 50. President Trump threatens to sign executive order on voter ID. Government is partially shut down again. Possible DNA match on glove found near Nancy Guthrie's home and the day's biggest headlines. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ecoutez Ça va beaucoup mieux avec Jimmy Mohamed du 13 février 2026.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl examine a sweeping set of developments shaping American healthcare. From the first state-approved use of generative AI to prescribe medications without human oversight to rising healthcare costs, from worsening vaccine misinformation to the stubborn persistence of preventable disease, this show focuses on biggest stories in medicine today. The episode opens with a groundbreaking and controversial pilot program in Utah that allows a generative AI system to renew prescriptions for chronic disease without physician involvement. From there, the conversation turns to the relentless rise in healthcare spending. New federal data show Americans now spend more than $15,700 per person annually on medical care, with costs growing twice as fast as the economy. While insurance coverage remains high for now, Pearl warns that expiring subsidies, Medicaid restrictions and rising premiums are already pushing millions out of coverage. For many families, healthcare affordability has become a top issue and, increasingly, a political fault line heading into the midterm election cycle. Here are more major storylines from MTT episode 103: Exercise as medicine for depression: A large meta-analysis finds that regular exercise can be as effective as antidepressant medication for many patients. Trump's healthcare plan fades quickly: Pearl explains why the president's proposal disappeared from the headlines. Measles returns in force: Cases are nearing 1,000 and outbreaks concentrated in under-vaccinated communities. Vaccine battles intensify under RFK Jr.: New appointments to federal advisory committees raise alarm among scientists, as anti-vaccine voices gain influence. Chronic disease remains America's top killer: Cardiovascular disease continues to claim nearly one million lives annually. Generative AI's biggest promise: Pearl makes the case that AI-driven, at-home monitoring could finally transform chronic disease management. Cancer trends turn ominous: Colorectal cancer deaths among Americans under 50 are rising sharply, becoming the leading cancer killer in this age group. Genetics vs. lifestyle revisited: New research suggests genetics may account for half of lifespan variation but lifestyle still determines how many of those years are lived in good health. High-deductible health plans: New data show cancer patients with high-deductible insurance have significantly higher mortality. GLP-1 weight-loss pills arrive: The first oral GLP-1 drug launches to record demand. A devastating flu season for children: Despite the availability of safe vaccines, pediatric flu deaths reach alarming levels among unvaccinated kids. As the episode closes, Dr. Pearl delivers a stark warning about the resurgence of pseudoscience in medicine. Tune in for more fact-based coverage and analysis of healthcare's biggest stories.   * * * Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn The post MTT #103: Can generative AI safely prescribe medicine on its own? appeared first on Fixing Healthcare.

Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer This study analyzed data from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial to look for an association between alcohol intake and colorectal cancer (CRC) or colorectal adenoma. Participants' lifetime pattern of alcohol intake was determined from a dietary history recorded as part of the PLCO trial. Current drinkers with a lifetime average of over 14 drinks per week had a higher CRC risk than those with under 1 drink per week (HR 1.25, p = .003) and an even higher risk of rectal cancer (HR 1.95). There was no consistent association between alcohol intake and colorectal adenoma risk, however results suggested that former drinkers may have a reduced risk of adenoma. They discussed potential mechanisms such as acetaldehyde, a known carcinogen and product of alcohol metabolism, and effects of alcohol on gut microbiome. They conclude that heavy alcohol intake increases CRC risk and that alcohol cessation may lower adenoma risk.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

La boisson qui augmente clairement le risque de cancer colorectal est l'alcool. Une vaste étude récente menée par l'American Cancer Society sur près de 88 000 à 90 000 personnes suivies pendant environ vingt ans met en lumière un facteur de risque encore largement sous-estimé : la consommation régulière d'alcool, même à des niveaux considérés par beaucoup comme « modérés ».Les chercheurs ont observé que les personnes ayant consommé en moyenne plus de 14 verres d'alcool par semaine au cours de leur vie présentent un risque significativement plus élevé de développer un cancer colorectal que celles qui boivent très peu ou pas du tout. Cette quantité correspond approximativement à deux verres par jour. Le risque est encore plus marqué pour le cancer du rectum, avec une augmentation particulièrement nette chez les consommateurs réguliers et de longue durée. Ce résultat est important, car il montre que ce n'est pas seulement l'excès ponctuel qui compte, mais bien l'exposition cumulée à l'alcool sur des années.Un point essentiel de cette étude est qu'elle ne met pas en cause une boisson spécifique comme le vin, la bière ou les spiritueux. Le facteur commun est l'éthanol, l'alcool présent dans toutes ces boissons. Autrement dit, peu importe le type d'alcool : c'est la molécule elle-même qui est associée au risque de cancer.Sur le plan biologique, plusieurs mécanismes expliquent ce lien. Lorsque l'organisme dégrade l'alcool, il produit une substance appelée acétaldéhyde, qui est toxique et capable d'endommager l'ADN des cellules. Ces dommages peuvent favoriser l'apparition de mutations et, à long terme, la transformation de cellules normales en cellules cancéreuses. L'alcool favorise aussi l'inflammation chronique, perturbe l'équilibre du microbiote intestinal et peut affaiblir les systèmes de réparation cellulaire. Dans le côlon et le rectum, où les cellules se renouvellent rapidement, ces effets créent un terrain propice à la cancérisation.Cette étude s'inscrit dans un ensemble de données scientifiques cohérentes montrant que l'alcool est impliqué dans de nombreux cancers, notamment ceux de la bouche, de la gorge, de l'œsophage, du foie, du sein et du tube digestif.Le message clé pour le public est simple : plus la consommation d'alcool est élevée et prolongée dans le temps, plus le risque de cancer colorectal augmente. Réduire sa consommation, instaurer des jours sans alcool et rester en dessous de deux verres par jour constitue une mesure de prévention concrète et efficace.En résumé, la boisson incriminée n'est pas un soda, un café ou une boisson énergisante, mais bien l'alcool, un facteur de risque majeur souvent banalisé, alors qu'il joue un rôle important dans le développement du cancer colorectal. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Today's conversation is a powerful reminder that what we often call cutting-edge technology is, in many ways, a return to deeply rooted truth.I'm honored to welcome Scott Hickle, CEO and co-founder of Throne Science, a revolutionary health-tech company reimagining how we understand digestive health. Alongside John Capodilupo, one of the original founders of WHOOP—Scott brings together deep experience in biometric data, human performance, and preventive health.At first glance, Throne's innovation—a smart toilet that analyzes stool and urine to generate personalized health insights—may sound futuristic. But when we look through the lens of Ayurveda, this technology feels incredibly familiar. In Ayurvedic medicine, stool analysis has always been one of the most important diagnostic tools. Long before lab tests and imaging, practitioners observed the color, consistency, frequency, smell, and ease of elimination to understand digestion, metabolism, nervous system balance, and even emotional health. Ayurveda teaches that when digestion is strong and elimination is clear, vitality—ojas—naturally follows.What Throne Science is doing is translating this ancient, embodied practice into a modern, accessible, and data-driven format—one that empowers individuals to self-observe, self-educate, and reconnect with their bodies in real time.This is especially important in the context of preventive care. Colorectal cancer is now one of the leading causes of cancer-related deaths, and rates are rising even among younger populations. Digestive dysfunction often whispers long before it screams—but in modern life, we're rarely taught how to listen. Throne offers a way to notice subtle changes early, without fear, shame, or disruption to daily life.From an Ayurvedic perspective, this is deeply aligned with the principle of svastha—being rooted in the self. Health is not something handed to us by a practitioner or a system; it's something we cultivate through awareness. Throne Science puts the keys back in our hands, transforming one of the most overlooked daily rituals into an act of self-inquiry and empowerment.We are living in a really exciting moment—where modern health technology is opening the gateway back to a wisdom system that is over 10,000 years old. Today's conversation is about championing that bridge: how ancient knowledge and advanced technology can work together to help us understand our bodies more deeply, prevent disease more intelligently, and reclaim a sense of agency in our health journeys.Send us a textFor 20% off Kerala Ayurveda products, use code OjasOasis at checkoutFor 20% off GarryNSun products, use code OJASOASIS20 at checkoutFor 20% off Ora Cacao products, use OJASOASIS20 at checkout Receive $500 off your Panchakarma retreat at SoHum Healing Resort with code OjasOasisPK2025 Support the showTo learn more about working with us, please visit www.OjasOasis.com Connect with us @ojasoasis on Instagram, X, TikTok, and YouTube

Local media are trying to pretend that a 10-year-old girl was arrested by Border Patrol in Spokane. Guest: State Rep. Brian Burnett (R-Chelan) on Democrats' attack on elected sheriffs. // LongForm: GUEST: KIRO News Radio's Chris Sullivan on this weekend's traffic nightmare during the Seahawks and Kraken games. // Quick Hit: Scientists are developing a new sleep apnea pill. Colorectal cancer is particularly deadly for one group of Americans.

On today’s episode of Ask the Dr, Dr. Michael Lange is joined by Roger Schulman for an important discussion on colorectal cancer and natural ways to help reduce risk. They talk about lifestyle and nutrition strategies that support gut health, overall wellness, and longevity. The focus is not just on surviving, but on truly thriving as we age. Topics discussed include: • Colorectal cancer and prevention-focused lifestyle choices • Natural ways to support gut and colon health • The benefits of Creapure creatine, MyHMB, and vitamin D • How Fortifeye Creatine + MyHMB + Vitamin D can support muscle, strength, and cognitive function • Why resistance training is essential for healthy aging and longevity • The importance of eating more fruits and vegetables • The role of omega-3s in RTG form for inflammation, heart, and brain health A powerful call-in from Tony: Tony calls into the show to share his incredible transformation, having lost over 250 pounds. He discusses how building muscle, improving his nutrition, and using proper supplementation dramatically improved his blood chemistries, overall systemic health, and ocular health. His journey is a real-life example of what is possible when you commit to lifestyle change and longevity-focused habits. Dr Lange mentions the Fortifeye Fit Meal is in manufacturing now and should be available soon. He also mentioned Fortifeye Fit Bites will be a chocolate raspberry gummy avaialble soon to curb appetite Special reminder: The last day for the BOGO on Fortifeye Vegan Super Protein is Monday. This episode is packed with practical, real-world strategies to help you build muscle, protect your brain, improve gut health, and thrive long term. Like, subscribe, and share Ask the Dr with anyone who wants to thrive, not just survive. #GutHealth #MuscleBuilding #ResistanceTraining #CognitiveHealth #TotalBodyWellness #fortifeyefitmealSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

Colorectal cancer is rising in younger adults, with U.S. rates increasing 2.4% per year since 2012. New evidence points to dietary changes as a contributing factor A recent study in JAMA Oncology found that those consuming the most ultraprocessed foods had a 45% higher risk of developing precancerous colorectal tumors before age 50 Risk increased with higher ultraprocessed food intake, then plateaued beyond seven to eight servings daily. Sweetened beverages, sauces, spreads, and condiments showed the strongest links You can reduce ultraprocessed food intake by planning real meals, replacing snack foods with whole ingredients, tracking triggers, and making unprocessed options more visible and accessible in your home Lowering your linoleic acid intake, increasing fiber gradually, and supporting gut health with protective foods and habits also helps reduce your risk of colorectal cancer

The number of candidates vying to replace Kentucky's retiring U.S. Senator Mitch McConnell grows to 19, Louisville Public Media journalist Joe Sonka talks about why so many Republicans will be unchallenged this election year and how a new state law that went into effect January 1st aims to lower the number of colorectal cancer deaths in Kentucky.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/NYM865. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until December 10, 2026.Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Pfizer.Disclosure information is available at the beginning of the video presentation.

Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library.  Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2026 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts.   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   Check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Behind the Knife in Español - repaso para el examen de certificación en cirugía general: https://app.behindtheknife.org/premium/repaso-para-el-examen-de-certificaci-n-en-cirug-a-general

Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam. Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheet Be sure to check out our free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library.  Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.app Behind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2026 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.html If you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts.   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   Check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Behind the Knife in Español - repaso para el examen de certificación en cirugía general: https://app.behindtheknife.org/premium/repaso-para-el-examen-de-certificaci-n-en-cirug-a-general

Dr. Tina Kaczor and Dr. Leah Sherman discuss new diagnostic tools that can tell benign tumors from cancer in the pancreas, highlight the growing concerns over microplastics, and explore the link between ultra-processed foods and early colorectal cancer. They also highlight some amazing inventions by teenagers, like a melanoma-detection app and a skin-cancer-reducing soap. Last, they cover the benefits of hypnosis before breast cancer surgery and the health impact of commonly used chemicals in dry cleaning. This episode provides valuable insights for anyone interested in cancer prevention, early diagnosis, and overall wellness.Soap for skin cancers invented by TIME's Kid of the Year, Hemen BekeleA skin cancer detecting app invented by Richmond, VA high-schoolersThe dramatic increase in glyphosate use across the Midwest in the USAThe rising rates of cancer in young people around the worldExposure of rat fetuses to glyphosate levels led to early cancer developmentThe rising rate of glyphosate exposure over time Support the showBecome a member of The Cancer Pod Community! Gain access to live Q&As, exclusive content, and so much more! Join us today! Check out our website! Looking for more information? We have blogs, merch, and all of our episodes listed by season and category. Shop our favorite reads! We've joined with Bookshop.org to offer some of our fave books! Have a comment or suggestion? Email us at thecancerpod@gmail.com Follow us wherever you browse. We're always @TheCancerPod: Instagram Bluesky Facebook LinkedIn YouTube THANK YOU!!

In this special two-part episode of Onc Now, Catherine Glass takes you through the incredible line-up of guests from 2025. From award winners to pioneering clinicians and researchers, this podcast has spotlighted some of the leading voices in the field of oncology. Explore their most impactful insights and hear how recent advances are shaping clinical practice and future research.  Timestamps:       00:00 – Introduction  1:17 – Importance of palliative care  5:55 – Obesity and carcinogenesis  9:28 – Colorectal cancer advances  12:06 – Navigating fertility preservation  15:06 – ESGO 2025 reflections  17:44 – The future of cancer vaccines  22:18 – Impact of diet on prostate cancer 

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths globally. While early detection significantly improves outcomes, many patients are diagnosed at advanced stages when treatment options are limited and relapse is common. To address this challenge, researchers are exploring whether existing drugs can be repurposed for cancer therapy, a strategy that could accelerate drug development while reducing associated costs and risks. One class of drugs under investigation is statins, commonly prescribed to reduce cholesterol and prevent cardiovascular disease. Several studies have observed a potential link between elevated cholesterol and increased CRC risk. Cholesterol may support tumor growth by promoting membrane synthesis and energy metabolism in rapidly dividing cells. Building on this connection, researchers from leading Indian institutions, including the Indian Institute of Science Education and Research and the Center of Excellence in Epigenetics at Shiv Nadar Institution of Eminence, investigated how statins influence CRC cells at the molecular level. Their goal was to determine whether these widely used drugs could have a therapeutic role in oncology. The Study: Investigating the Molecular Impact of Statins in CRC Cells The study, titled “Statins exhibit anti-tumor potential by modulating Wnt/β-catenin signaling in colorectal cancer,” was published in Oncotarget (Volume 16). Using a combination of lipidomics, transcriptomics, proteomics, and 3D tumor models, the researchers explored how two widely prescribed statins, atorvastatin and simvastatin, affect molecular pathways associated with CRC progression. This integrative, multi-omics strategy enabled tracing statin-induced effects across different layers of cellular function, linking lipid, transcript, and protein changes to pathway-level shifts. Full blog - https://www.oncotarget.org/2025/12/03/repurposing-statins-exploring-anti-tumor-effects-in-colorectal-cancer/ Paper DOI - https://doi.org/10.18632/oncotarget.28755 Correspondence to - Sanjeev Galande - sanjeev.galande@snu.edu.in Abstract video - https://www.youtube.com/watch?v=A95ICULaH3Y Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28755 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, colorectal cancer, statins, SATB1, Wnt/β-catenin signaling, tumor-suppressive phenotype To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Hi. It’s me. James VanOsdol. As my recent (and forthcoming) guest hosts continue to kill it, I’m finally in a physical and emotional place where I can check in and let you know everything that’s been going on with me. This isn’t a traditional episode - it didn’t make sense to read sponsor tags or play the theme song - instead, it’s a full recounting of all the medical stuff going on with me since October. Thank you for your continued support! As I mention toward the end, while I haven’t always been able to respond to all my messages, I’ve read them all and they mean a great deal to me.See omnystudio.com/listener for privacy information.

In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Mecker G. Möller crucial questions regarding colorectal peritoneal metastasis (CRC-PM) management, particularly concerning the optimal applications of HIPEC in clinical practice, as reported in the article, "Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?"

In this episode, Drs. Ali, Georgoff, and Swenson share some big-time updates to our oral board simulator.  We've also included a full example test for you to listen to. Whether you are studying for the exam, or for your next rotation, try the Behind the Knife Oral Board Simulator for free: https://behindtheknifeoralboardsimulator.org What's new: Massive Usage & Feedback: The Beta launch of the AI-powered oral board simulator has been a huge success, thanks to the incredible support and actionable feedback from the surgical community.  Your feedback has allowed for advanced fine tuning and a better user experience. Next-Level Feedback: Your readiness score just got a whole lot more honest! The score is now a more accurate reflection of your performance and the number of the 362 testable conditions and procedures you've actually covered. The Examiner Makeover: Experience a real-world test day with 20 different examiner voices (fast, slow, accented) to prepare you for any personality you might face. Introducing your new study partners: Get ready for three game-changing features designed to elevate your training: Coach: The ultimate study buddy! Ask it questions, and it will provide the right answers, identify your weaknesses, and walk you through scenarios (the opposite of the unhelpful examiner!). OpGuide: Perfect for procedural review. Ask it how to perform a procedure (like a Whipple), and it will provide concise, board-appropriate surgical steps. Wingman: Practice unfamiliar topics without the stress! It presents a patient stem, and if you're stuck, Wingman will answer for you in the first person, teaching you the topic as it goes. The future is now! Specialty Expansion: The simulator is coming soon to Vascular, Colorectal, Surgical Oncology, CT Surgery, Pediatric Surgery, and even OBGYN! Platform Integration: Look out for a big makeover as the simulator is fully integrated into the Behind the Knife app platform for a seamless and beautiful user experience. Listen to the end for a full scenario run-through and a detailed breakdown of the scoring to see the improvements for yourself! Your feedback is CRUCIAL to making this the best simulator it can be. Please use the in-app feedback button or the link below to share your thoughts! https://forms.gle/wAJxTtkEYowNeqNa9 Hosts: - Ayman Ali, MD (PGY-4, Duke Hospital) - Patrick Georgoff, MD (Trauma/Critical Care Surgeon, Duke Hospital): @georgoff - Matthew Swenson, MD (General Surgeon, Valley Health System) Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Liver transplantation can extend survival for some patients whose colorectal cancer has spread only to the liver. Robert Cannon, M.D., surgical director of UAB's Liver Transplant Program, explains the selection criteria that determine whether these patients — until recently considered ineligible for transplant — may benefit. He also outlines the treatment progression and how physicians care for patients while they are on the transplant waiting list. Learn how the RAPID graft technique and UAB's new living-donor program could make this option available to more patients.

10/26/25The Healthy Matters PodcastS05_E02 - Gut Check:  Colon Cancer 101With Special Guest:  Dr. Jake Matlock, MDColon cancer isn't exactly dinner-table conversation, but maybe it should be.  Behind the awkward jokes and uncomfortable colonoscopy prep lies one of the most preventable forms of cancer out there.  But how does colon cancer develop?  Who's most at risk?  And can screening and early detection really save your behind?On Episode 2 of our show, Dr. Hilden sits down with gastroenterologist, Dr. Jake Matlock to go through everything from prevention to treatment.  We'll cover the basics of the condition, weigh the merits of available screening options and discuss the best practices for staying healthy.  When it comes to colon health, a little knowledge (and a little humor) goes a long way.  We hope you'll join us.Got healthcare questions or ideas for future shows?Email - healthymatters@hcmed.orgCall - 612-873-TALK (8255)Get a preview of upcoming shows on social media and find out more about our show at www.healthymatters.org.

A top surgeon believes there's an urgent need for dedicated cancer centres around the country as the number of people diagnosed with the disease is set to balloon and the gap in outcomes is widening. Colorectal surgeon, Professor Frank Frizelle said comprehensive cancer centres are not novel experiments but rather best practice around the world. He said they are a necessity for New Zealand for sustained improvements in cancer outcomes. Professor Frank Frizelle spoke to Lisa Owen.

Study Discovers Increased Cancers After MRNA Vaccines, Bret Weinstein- Covid & mRNA: Harms and Damages Exposed Bret Weinstein- Covid & mRNA: Harms and Damages Exposed (NEW!) REMINDER: CDC Didn't Track VAERS Safety Signals John Campbell- Increased cancers after mRNA vaccines   Study- Covid & mRNA: Harms and Damages Exposed (NEW!) | DarkHorse https://youtu.be/zkrbZmYuRoY?si=_0yO0y5ftLacoVJ1 Bret Weinstein 512K subscribers 25,699 views Sep 5, 2025 A new article on the harms and hazards of both SARS-CoV2 and the mRNA biologics said to counter the virus. Full Episode: https://youtube.com/live/wQWkKrM3Dt8 Mentioned in this segment: Zywiec et al 2025. COVID-19 Injections: Harms and Damages, a Non-Exhaustive Conclusion. Journal of American Physicians and Surgeons, 30(3): https://jpands.org/vol30no3/zywiec.pdf ***** Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.com Heather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.com Our book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned) Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org   REMINDER: CDC Didn't Track VAERS Safety Signals | DarkHorse https://youtu.be/u3UAyr6s7xc?si=VUoenskCyMdViArS Bret Weinstein 512K subscribers 16,906 views Sep 5, 2025 RFK Jr. fires the new director, after which other CDC officials resign, and eight former directors of the CDC pen a letter to the New York Times arguing that Kennedy is a hazard to our health. Bret Weinstein and Heather Heying discuss "The Plot Against Kennedy" in Episode 292 of The Evolutionary Lens. Full Episode: https://youtube.com/live/wQWkKrM3Dt8 Mentioned in this segment: NYT op-ed #2 from former CDC directors: We Ran the C.D.C.: Kennedy Is Endangering Every American's Health: https://www.nytimes.com/2025/09/01/op... Bret and Heather 132nd DarkHorse Podcast Livestream: 50 States not in a Roe https://youtube.com/live/usP2D_qGUZs CDC didn't monitor VAERS for COVID safety signals (June 2022): https://childrenshealthdefense.org/de...   Increased cancers after mRNA vaccines Watch this video at- https://youtu.be/3dnIGqUlluc?si=sDbAdXTgOsCiCLev Dr. John Campbell 3.25M subscribers 143,152 views Sep 5, 2025 COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province https://pubmed.ncbi.nlm.nih.gov/40881... https://pmc.ncbi.nlm.nih.gov/articles... https://www.thefocalpoints.com/p/brea... The rate of first hospitalization for cancer of any site Unvaccinated group: 0.85% Vaccinated group (one or more doses): 1.15% N = 296,015 population Hospital admission with a cancer diagnosis, 3,124 (p less than 0.001). Vaccination with at least one dose Colon-rectal cancer HR: 1.34 Breast cancer HR: 1.54 Bladder cancer HR: 1.62 After three or more vaccine doses Breast cancer HR: 1.36 Bladder cancer HR: 1.43 All significant After one dose (180 days after) Rate of first hospital admissions for cancers All cancers: up 23% significant Colorectal: up 34% significant Lung: down = 10% Breast: up 54% significant Uterine: up = 75% Ovarian: up = 65% Prostate: up = 1% Bladder: up 62% significant Thyroid: up =58% Haematological: up = 33% After three dose (180 days after administration of third dose) All cancers: up = 9% Colorectal: up = 14% Lung: down = 5% Breast: up=36% significant Uterine: up = 20% Ovarian: up = 86% Prostate: down = 3% Bladder: up=43% significant Thyroid: down = 3% Haematological: up = 5% More about the study Population-wide cohort analysis Evaluating the risk of all-cause death and cancer hospitalization by SARS-CoV-2 immunization status. National Health System official data, entire population, Pescara province, Italy Followed from June 2021 (six months after the first vaccination) to December 2023. 296,015 residents aged ≥11 years Hospital admission with a cancer diagnosis, 3,124 16.6% were unvaccinated 83.3% received ≥1 dose 62.2% ≥3 doses. Compared with the unvaccinated, those receiving ≥1 dose showed a significantly lower likelihood of all-cause death Cancer hospitalization was significant only among the subjects with no previous SARS-CoV-2 infection Some cancer risks went down after 1 year (relative to 180 days) (But breast, ovarian and bladder went up at one year relative to 180 days after 1 vaccine dose) Given that it was not possible to quantify the potential impact of the healthy vaccinee bias and unmeasured confounders, these findings are inevitably preliminary.